Story perspectives

Trump's Tariff Plan Threatens Drug Supply and Prices

4/19/2025

50 9

Summary

Story summary

President Trump's administration is probing tariffs on pharmaceuticals and semiconductors, targeting suppliers from Europe, India, and Canada. Experts caution that these tariffs could unravel supply chains and exacerbate drug shortages in the U.S. While intended to bolster domestic manufacturing, they risk inflating consumer prices and straining economies in impacted regions.

History

Historical Context

President Trump's administration's consideration of tariffs on pharmaceuticals and semiconductors echoes historical U.S. trade policies, notably the Emergency Tariff of 1921 and the Fordney-McCumber Tariff of 1922, aimed at protecting domestic industries. Such tariffs often disrupt supply chains and can lead to inflation, reminiscent of the economic challenges faced during the Great Depression when protectionist measures exacerbated global trade tensions.

1 of 2

Story summary

President Trump's administration is probing tariffs on pharmaceuticals and semiconductors, targeting suppliers from Europe, India, and Canada. Experts caution that these tariffs could unravel supply chains and exacerbate drug shortages in the U.S. While intended to bolster domestic manufacturing, they risk inflating consumer prices and straining economies in impacted regions.

1 / 2